Urges Congress to pass "Improving Menopause Care for Veterans Act of 2025."
Summary
Assembly Resolution 135 is a New Jersey resolution that urges the United States Congress to pass the federal “Improving Menopause Care for Veterans Act of 2025.” The resolution focuses on women veterans, especially those ages 40 to 54, and explains that many are likely to experience perimenopause or menopause during or after military service. It describes common symptoms such as hot flashes, sleep disturbances, mood changes, brain fog, urinary issues, and sexual dysfunction, and notes that these symptoms can be overlooked or misattributed, delaying treatment.
The resolution states that the federal bill would direct the Comptroller General to study VA medical services for veterans experiencing menopause-related symptoms and would require the Secretary of Veterans Affairs to improve access to and the quality of menopause care. AR135 itself does not change New Jersey law; instead, it is an expression of the General Assembly’s support for federal action and a formal request that Congress and the VA address menopause care for women veterans. It also directs copies of the resolution to congressional leaders, New Jersey’s congressional delegation, and the Secretary of Veterans Affairs.
Impact
AR135 has no direct effect on New Jersey statutes, regulations, or state agency duties. Its legal impact is limited to a formal legislative endorsement of federal legislation and a communication to federal officials. The practical policy effect is to add New Jersey’s support to efforts to expand VA study, access, and quality of care for menopause and perimenopause treatment for women veterans.
Sentiment
The overall sentiment is strongly supportive and sympathetic toward women veterans. The resolution is framed as a recognition of the health challenges many veterans face and as an effort to improve quality of life, careers, relationships, and long-term health. No committee debate, vote record, or recorded opposition is provided in the available context, so the bill appears to be presented without documented controversy in the materials supplied.
Contention
The resolution itself does not present internal controversy, but the underlying policy issue is the need for the VA to better recognize and treat menopause-related symptoms, which may be underdiagnosed or misattributed to stress, aging, anxiety, or depression. The bill also implies a broader point of contention in federal policy: whether the VA is adequately tailored to the needs of women veterans and whether menopause care should be a specific focus of VA study and service improvement. No named opponents or dissenting arguments are included in the provided record.